References
1. International Union of Immunological Societies. Primary immunodeficiency diseases: report of an IUIS Scientific Committee. Clin Exp Immunol 1999; 118:1-28.
2. Woo CK, Bahna SL. Evaluation of the child with immunodeficiency disorder. Pediatr Ann 2011;40:205-211.
3. Coico R, Sunshine G, Benjamini E.Immunology. A Short Course. 5th ed. Hoboken, NJ: John Wiley & Sons; 2003.
4. Alqudah M, Graham SM, Ballas ZK. High prevalence of humoral immunodeficiency patients with refractory chronic rhinosinusitis. Am J Rhinol Allergy 2010;24:409-412.
5. Uzzaman A, Fuleihan RL. Approach to primary immunodeficiency. Allergy Asthma Proc 2012;33:91-95.
6. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999; 92:34-48.
7. Hermaszewski RA, Webster AD. Primary hypogammaglobulinemia: a survey of clinical manifestations and complications. Q J Med 1993;86:31-42.
8. Wood P, Stanworth S, Burton J, et al. Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review. Clin Exp Immunol 2007;149:410-423.
9. Sorensen RU, Moore C. Antibody deficiency syndromes. Pediatr Clin North Am 2000;47:1225-1252.
10. Reda S, El-Ghoneimy D, Afifi H. Clinical predictors of primary immunodeficiency diseases in children.Allergy Asthma Immunol Res2013;5:88-95.
11. Notarangelo L. Primary immunodeficiencies. J Allergy Clin Immunol 2010; 125:S182-S194.
12. Bonilla FA, Bernstein IL, Khan DA, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol 2005;94:S1-S63.
13. Litzman J, Burianova M, Thon V, et al. Progression of selective IgA deficiency to common variable immunodeficiency in a 16 year old boy. Allergol Immunopathol (Madr) 1996;24:174-176.
14. Liblau RS, Bach JF. Selective IgA deficiency and autoimmunity. Int Arch Allergy Immunol 1992;99:16-27.
15. Munks R, Booth JR, Sokol RJ. A comprehensive IgA service provided by a blood transfusion center. Immunohematology 1998;14:155-160.
16. Driessen G, van der Burg M. Educational paper: primary antibody deficiencies. Eur J Pediatr 2011;170:693-702.
17. Hammarstrom L, Vorechovsky I, Webster D. Selective IgA deficiency (SigAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 2000;120:225-331.
18. Etzion A. Immune deficiency and autoimmunity. Autoimmun Rev 2003;2:364-369.
19. Chapel H, Cunningham-Rundles C. Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol 2009;145:709-727.
20. Webster DB. Common variable immunodeficiency. Humoral immunodeficiencies. Immunol Allergy Clin North Am 2001;21:1-22.
21. Cunningham-Rundles C. Common variable immunodeficiency. Curr Allergy Asthma Rep 2001;1:421-429.
22. Papadopoulou-Alataki E, Hassan A, Davies EG. Prevention of infection in children and adolescents with primary immunodeficiency disorders.Asian Pac J Allergy Immunol 2012;30:249-258.
23. Yong PL, Boyle J, Ballow M, et al. Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies. A working group report of and study by the Primary Immunodeficiency Committee of the American Academy of Allergy Asthma and Immunology. Clin Immunol 2010;135:255-263.
24. Tarzi MD, Grigoriadou S, Carr SB, et al. Clinical immunology review series: an approach to the management of pulmonary disease in primary antibody deficiency. Clin Exp Immunol 2009;155:147-155.
25. Ochs HD, Stiehm ER, Winkelstein JA, et al. Antibody deficiencies. In: Immunological Disorders in Infants and Children. 5th ed. Philadelphia:Elsevier; 2004.
27. Umetsu DT, Ambrosino DM, Geha RS. Children with selective IgG subclass deficiency and recurrent sinopulmonary infection: impaired response to bacterial capsular polysaccharide antigens. Monogr Allergy 1986;20:57-61.
28. Soderstrom T, Soderstrom R, Avanzini A, et al. Immunoglobulin G subclass deficiencies.Int Arch Allergy Appl Immunol 1987;82:476-480.
29. Buckley RH. Immunoglobulin G subclass deficiency: fact or fancy?Curr Allergy Asthma Rep 2002;2:356-360.
30. Durandy A, Kaveri SV, Kuijpers TW, et al. Intravenous immunoglobulins-understanding properties and mechanisms. Clin Exp Immunol 2009;158:2-13.
31. Wilson CB, Lewis DB, Penix LA. The physiologic immunodeficiency of immaturity. In: Immunological Disorders in Infants and Children. Philadelphia: WB Saunders; 1996.
32. Bonilla F. Antibody deficiency. In: Leung DYM, Sampson H, Geha R, et al, eds. Pediatric Allergy: Principles and Practice. Philadelphia:Mosby; 2003:88-98.
33. Ballow M, Cates KL, Rowe JC, et al. Development of the immune system in very low birth weight (less than 1500 g) premature infants; concentrations of plasma immunoglobulins and patterns of infections. Pediatr Res 1986;20:899-904.
34. Winkelstein JA, Marino MC, Lederman HM, et al. X-linked agammaglobulinemia: a report on a United States registry of 201 patients. Medicine (Baltimore) 2006;85:193-203.
35. Vetrie D, Vorechovsky I, Sideras P, et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 1993;361:226-233.
36. Buckley R. Primary B-cell diseases. In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson Textbook of Pediatrics. 16th ed. Philadelphia: WB Saunders; 2000:596-599.
37. Cham B, Bonilla MA, Winkelstein J. Neutropenia associated with primary immunodeficiency syndromes. Semin Hematol 2002;39;107-112.
38. Winkelstein JA, Marino MC, Ochs H, et al. The X-linked hyper-IgM syndrome: clinical and immunological features of 79 patients. Medicine (Baltimore) 2003;82:373-384.
39. Conley ME, Dobbs AK, Farmer DM, et al. Primary B cell immunodeficiencies: comparisons and contrasts. Annu Rev Immunol 2009;27:199-227.
40. Carneiro-Sampaio M, Coutinho A. Immunity to microbes: lessons from primary immunodeficiencies. Infect Immun 2007;75:1545-1555.
42. Levy J, Espanol-Boren T, Thomas C, et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 1997;131:47-54.
43. Garcia JM, Gamboa P, de la Calle A, et al. Diagnosis and management of immunodeficiencies in adults by allergologists. J Invest Allergol Clin Immunol 2010;20:185-194.
44. Makhija M, O’Gorman MR. Common in vitro tests for allergy and immunology. Allergy Asthma Proc 2012;33:108-111.
45. Chapel HM, Spickett GP, Ericson D, et al. The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy. J Clin Immunol 2000;20:84-100.
46. Lucas M, Lee M, Lortan J, et al. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. J Allergy Clin Immunol 2010;125:1354-1360.
47. Kumar A, Teuber S, Gershwin M. Intravenous immunoglobulin: striving for appropriate use. Int Arch Allergy Immunol 2006;140:185-198.
48. Shehata N, Palda V, Bowen T, et al. The use of immunoglobulin therapy for patients with primary immune deficiency: an evidence-based practice guideline. Transfus Med Rev 2010;24:S28-S50.
49. Wu E, Frank M. The mystery of IVIg. Rheumatologist March 2012.
50. Ballow M. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders. J Allergy Clin Immunol 2011;127:315-323.
51. Nimmerjahn F, Ravetch JV. Anti-inflammatory actions of intravenous immunoglobulin. Annu Rev Immunol 2008;26:513-533.